Back to results
US 6,727,267 B2Granted
NS5B HVC polymerase inhibitors
AssigneeTularik Inc.
InventorsJuan C. Jaen, Jay P. Powers
Life of this patent
Estimating the term…
Abstract
Compounds, compositions and methods are provided that are useful in the treatment and prevention of certain viral infections and associated diseases. In particular, the compounds of the invention inhibit the activity of a viral RNA polymerase. The subject methods are particularly useful in the treatment of diseases causes by hepatitis C virus infection.
Claims4
A compound having the formula (VIIa):
- wherein
- Ar1 is selected from the group consisting of substituted or unsubstituted aryl and substituted or unsubstituted heteroaryl;
- X is selected from —S—, —O—and —N(RO)—, wherein RO is H or lower alkyl;
- Y is O or S;
- and
- Z is O, S or N(R2d), wherein R2d is H or lower alkyl, or R2d and R1 may be joined to form an imidazole or benzimidazole group;
- and
- R2 is a substituted or unsubstituted mono- or bi-heterocyclic group, a substituted or unsubstituted polycyclic ring, a substituted or unsubstituted alicyclic group having 5-8 carbon atoms, a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, a substituted or unsubstituted phenylether group, a substituted or unsubstituted cinnamenyl group, or a substituted or unsubstituted stilbenyl group.
5 more elements
The compound of claim,1 wherein said compound is selected from the group consisting of
Dependencies are inferred from the claim text.